UH Biology Student Contributes to Groundbreaking Cancer Discovery
A University of Houston biology student played a key role in a significant finding by MD Anderson Cancer Center researchers: the COVID vaccine can enhance immunotherapy treatment effectiveness, offering new hope to cancer patients worldwide.
Researchers presented their findings at the 2025 European Society for Medical Oncology Congress, revealing that patients who received mRNA-based COVID vaccines within 100 days of starting immunotherapy were twice as likely to survive three years after treatment as those who didn't receive the vaccine.
The COVID vaccine can enhance the effectiveness of immunotherapy treatments, offering new hope to cancer patients worldwide.
Author's summary: UH student aids in cancer discovery.
More News
- Changes to academic public health training will worsen the medical recruitment crisis
- Robotaxis’ Dream Regulator Takes The Wheel
- What Arsenal Must Do Next After a Stellar 2025/26 Transfer Window
- VIDE Report: St. Croix Leads in Student Growth as STT-STJ Dominates in Academic Proficiency; Both Districts Weak in Math
- John Ivison: Poilievre replays his old, conspiratorial hits as his leadership review nears
- Grace Wales Bonner joins Hermès as creative director of menswear – HERO
- Reform in turmoil: Party forced to suspend 4 more Kent councillors after bitter infighting
- Virginia raises bar for students while Illinois hides struggles
- 2025 Atlanta Braves Player Review: Cal Quantrill
- This Day in Braves History: Greg Maddux shines in game two win over Yankees in World Series